# Chinadiagnosticmedicalcorporationcdmc

**Canonical:** https://apis.io/providers/chinadiagnosticmedicalcorporationcdmc/  
**Website:** https://dcndx.com  
**APIs profiled:** 1

DCN Dx (China Diagnostic Medical Corporation) is a Carlsbad, California‑based IVD contract development and manufacturing organization (CDMO) and clinical research organization (CRO). It offers immunoassay development, lateral flow and ELISA production, regulatory consulting, and biospecimen collection services for diagnostic developers pursuing FDA and EU approvals. ISO 13485 and ISO 9001 certified, serving global partners in medical diagnostics.

## Kin Score — 10.0 / 100 (minimal)

Scored 2026-10-09 under rubric 0.23.0.

| Facet | Score |
|---|---|
| Discoverability | 60.7 |
| Contract Quality | 0.0 |
| Contract Governance | 0.0 |
| Operational Transparency | 0.0 |
| Developer Ergonomics | 0.0 |
| Access Clarity | 21.1 |

Regulatory layer — **Horizontal (data, software, accessibility, platform)**: 13.7 (matched via fallback).

## Agent readiness — 3.1 (human-only)

| Dimension | Value |
|---|---|
| Spec Presence | no |
| Agentic Access | no |
| Reversibility Documented | no |
| MCP Server | documented |
| Auth Clarity | no |
| Idempotency | no |
| Error Semantics | no |
| OpenAPI Examples | no |
| Rate Limit Signal | no |
| Event Surface Described | no |
| Agent Skills | no |
| Well Known Catalog | no |
| Consent Identity | no |
| Agent Card | no |
| Dry Run Mode | no |
| Delegated Identity | no |
| Protected Resource Metadata | no |
| Dynamic Client Registration | no |
| Agentic Commerce | no |

## APIs (1)

- **DCN Dx API** — API information not publicly documented; no machine‑readable specification discovered.

## Security (1)

- **Chinadiagnosticmedicalcorporationcdmc Domain Security** — TLSv1.3 · DMARC

## Tags

Company, IVD, CDMO, CRO, Diagnostics, California

---

Profiled by [API Evangelist](https://apievangelist.com) and published on [APIs.io](https://apis.io/providers/chinadiagnosticmedicalcorporationcdmc/). Scores are computed from the provider's own public artifacts under a published rubric.